Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
Cell Reports. Medicine|September 11, 2024
Early-onset cancers: Biological bases and clinical implicationsGianluca Mauri, Giorgio Patelli, Andrea Sartore-Bianchi, et al.
Clinical Colorectal Cancer|December 3, 2017
Parallel Evaluation of Circulating Tumor DNA and Circulating Tumor Cells in Metastatic Colorectal CancerGiovanni Germano, Gianluca Mauri, Giulia Siravegna, et al.
Clinical Colorectal Cancer|March 17, 2016
Oxaliplatin Immune-Induced Syndrome Occurs With Cumulative Administration and Rechallenge: Single Institution Series and Systematic Review StudyKatia Bencardino, Gianluca Mauri, Alessio Amatu, et al.
Targeted Oncology|March 19, 2021
Liquid Biopsy for Prognosis and Treatment in Metastatic Colorectal Cancer: Circulating Tumor Cells vs Circulating Tumor DNAGiorgio Patelli, Caterina Vaghi, Federica Tosi, et al.
Cancers|March 10, 2022
Efficacy of Retreatment with Oxaliplatin-Based Regimens in Metastatic Colorectal Cancer Patients: The RETROX-CRC Retrospective StudyAlessio Amatu, Gianluca Mauri, Federica Tosi, et al.
Cancers|January 7, 2021
The Evolutionary Landscape of Treatment for <i>BRAF</i> Mutant Metastatic Colorectal CancerGianluca Mauri, Erica Bonazzina, Alessio Amatu, et al.
Cancer Treatment Reviews|October 22, 2020
Oxaliplatin retreatment in metastatic colorectal cancer: Systematic review and future research opportunitiesGianluca Mauri, Viviana Gori, Erica Bonazzina, et al.
Eclinicalmedicine|April 9, 2026
Locally advanced rectal cancer: what patients and practitioners should know about non-operative managementFederica Tosi, Giorgio Patelli, Pietro Carnevali, et al.
Clinical Colorectal Cancer|February 21, 2017
Effect of KRAS and BRAF Mutations on Survival of Metastatic Colorectal Cancer After Liver Resection: A Systematic Review and Meta-AnalysisFederica Tosi, Elena Magni, Alessio Amatu, et al.
Frontiers in Oncology|April 14, 2023
Corrigendum: Case report: <i>MAP2K1 K57N</i> mutation is associated with primary resistance to anti-EGFR monoclonal antibodies in metastatic colorectal cancerGianluca Mauri, Giorgio Patelli, Viviana Gori, et al.
Pageof 5